ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 425,18
0,28%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Javelin Pharmaceuticals (JAV)

  7. Javelin Pharmaceuticals (JAV) Actualités

JAV

Javelin Pharmaceuticals (JAV)

Javelin Pharmaceuticals
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:JAV
DateHeureSourceTitreSymboleSociété
07/07/201012h00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:JAVJavelin Pharmaceuticals
06/07/201019h14Edgar (US Regulatory)(25-NSE)AMEX:JAVJavelin Pharmaceuticals
02/07/201022h39Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)AMEX:JAVJavelin Pharmaceuticals
02/07/201022h24Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)AMEX:JAVJavelin Pharmaceuticals
02/07/201021h27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
02/07/201021h24Edgar (US Regulatory)Current report filing (8-K)AMEX:JAVJavelin Pharmaceuticals
01/07/201023h20Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)AMEX:JAVJavelin Pharmaceuticals
01/07/201020h59Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)AMEX:JAVJavelin Pharmaceuticals
01/07/201014h05Business WireJavelin Pharmaceuticals, Inc. Announces Successful Completion of Tender Offer for Its Common Stock by Hospira, Inc.AMEX:JAVJavelin Pharmaceuticals
30/06/201012h50GlobeNewswire Inc.Javelin Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comAMEX:JAVJavelin Pharmaceuticals
22/06/201000h23Dow Jones News2nd UPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201022h08Dow Jones NewsUPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201016h33Dow Jones NewsBusiness Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201014h30Business WireNews Release Service Inadvertently Issues Hoax Press Release Identifying Javelin Pharmaceuticals as IssuerAMEX:JAVJavelin Pharmaceuticals
11/06/201015h00Business WireJavelin Receives $2 Million Loan from HospiraAMEX:JAVJavelin Pharmaceuticals
07/06/201014h30Business WireJavelin Receives Notice from Hospira of Funding of LoanAMEX:JAVJavelin Pharmaceuticals
04/06/201022h05Business WireJavelin Receives Notice From NYSE Amex LLC of Non-ComplianceAMEX:JAVJavelin Pharmaceuticals
03/06/201013h30Business WireJavelin Commences Litigation against Hospira & Discus Acquisition Corporation, Asserts Hospira is in Breach of Merger Agreeme...AMEX:JAVJavelin Pharmaceuticals
26/05/201023h23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:JAVJavelin Pharmaceuticals
24/05/201015h05Business WireJavelin Pharmaceuticals, Inc. Provides Update to Dyloject™ UK Supply ChainAMEX:JAVJavelin Pharmaceuticals
19/05/201014h59Business WireJavelin Pharmaceuticals, Inc. Comments on Tender Offer Extension by HospiraAMEX:JAVJavelin Pharmaceuticals
10/05/201022h16Business WireJavelin Pharmaceuticals, Inc. Reports First Quarter 2010 ResultsAMEX:JAVJavelin Pharmaceuticals
10/05/201021h01Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:JAVJavelin Pharmaceuticals
22/04/201012h02Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)AMEX:JAVJavelin Pharmaceuticals
21/04/201023h06Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)AMEX:JAVJavelin Pharmaceuticals
19/04/201023h20Business WireKendall Law Group Investigating Javelin Pharmaceuticals, Inc. Merger AgreementAMEX:JAVJavelin Pharmaceuticals
19/04/201022h44Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)AMEX:JAVJavelin Pharmaceuticals
19/04/201018h47Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)AMEX:JAVJavelin Pharmaceuticals
19/04/201015h49Dow Jones NewsJavelin, Myriad Officially Terminate Buyout DealAMEX:JAVJavelin Pharmaceuticals
19/04/201014h50Business WireJavelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Sto...AMEX:JAVJavelin Pharmaceuticals
 Showing the most relevant articles for your search:AMEX:JAV

Dernières Valeurs Consultées

NASDAQ
CCTSW
Cactus Acquisition Corp 1
ASX
WICOC
Westoz Investment
NASDAQ
AAZXCXX
Bmo Harris Bank Na Point...
USOTC
AVCVF
Monitor Ventures (CE)
BIT
UC3T41
Unicredit Bank
LSE
AGY
Allergy Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés